Qiagen N.V.

Qiagen N.V. is a multinational biotechnology company headquartered in the Netherlands that provides sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Through its subsidiaries, Qiagen supplies a wide range of products and services to federal government agencies, primarily in support of biomedical research, public health, healthcare, and law enforcement programs. These offerings include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, bioinformatics software, and precision medicine analysis tools.

Qiagen's federal contract awards span multiple agencies, with significant work for the Department of Health and Human Services (including NIH, CDC, and FDA), Department of Veterans Affairs, Department of Defense, and Department of Justice. Key products and services provided under these contracts include QuantiFERON TB Gold Plus reagents for tuberculosis testing, EZ1 & EZ2 DNA Investigator Kits for forensic analysis, QIAcuity digital PCR systems, QIAsymphony automated sample preparation platforms, and CLC Genomics Workbench software for bioinformatics analysis. Qiagen also provides maintenance and support services for its instruments, as well as specialized reagents and consumables for various molecular biology applications. Many of these contracts are awarded without set-aside designations, reflecting Qiagen's status as a large, international corporation.

The provided information does not contain details about federal grant awards to Qiagen N.V. or its subsidiaries. As a commercial biotechnology company, Qiagen is more likely to engage with the federal government through contracts for products and services rather than receiving research grants. However, it's possible that Qiagen collaborates with academic or non-profit institutions on federally funded research projects, providing reagents, equipment, or technical expertise as a subcontractor or partner.

Qiagen holds several indefinite delivery vehicles (IDVs) with federal agencies, enabling efficient procurement of its specialized products and services. These include blanket purchase agreements (BPAs) and indefinite delivery/indefinite quantity (IDIQ) contracts with agencies such as the Department of Veterans Affairs, Defense Health Agency, and Federal Bureau of Investigation. Under these IDVs, Qiagen provides a range of molecular diagnostics products, reagents, and related services. For example, Qiagen has a BPA with the VA for PCR instrumentation platforms and supplies, and an IDIQ contract with the Defense Health Agency for infectious disease testing reagents and automated instrumentation. These IDVs allow agencies to quickly place orders for Qiagen's products and services as needed, streamlining the procurement process for recurring requirements.